Published in Medicine and Law Weekly, December 22nd, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Insmed.
Report 1: Insmed, Inc., (INSM) announced that it has sued Tercica, Inc., for allegedly false and misleading statements Tercica has made in advertising and promoting Increlex, Tercica's severe primary insulin-like growth factor deficiency (IGFD) treatment.
In a counterclaim filed in the United States District Court for the Eastern District of Virginia, Insmed charges that Tercica has made numerous unlawful, false, and misleading statements about Increlex and/or IPLEX, according to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly